060280 — CUREXO Income Statement
0.000.00%
Last trade - 00:00
- KR₩503bn
- KR₩471bn
- KR₩73bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 34,388 | 39,282 | 42,795 | 64,991 | 72,882 |
Cost of Revenue | |||||
Gross Profit | 5,563 | 9,359 | 9,056 | 14,389 | 19,298 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 41,558 | 39,296 | 47,835 | 65,649 | 71,747 |
Operating Profit | -7,170 | -14.2 | -5,040 | -658 | 1,135 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -25,918 | 419 | -2,320 | -2,933 | -4,760 |
Provision for Income Taxes | |||||
Net Income After Taxes | -25,918 | 417 | -2,342 | -3,041 | -4,856 |
Net Income Before Extraordinary Items | |||||
Net Income | -25,918 | 417 | -2,342 | -3,041 | -4,856 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -25,918 | 417 | -2,342 | -3,041 | -4,856 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -691 | 28.4 | -7.29 | -52.2 | -120 |
Dividends per Share |